Lcn2 transcription has already been shown to be dependent on NF-κB activation in breast and thyroid cancer cells [2,10,11] and NF-κB has been shown to bind to the Lcn2 promoter [11]. This evidence concerns the gene NFKB1 and thyroid cancer.